Mesa Labs Declares Quarterly Dividend
Mesa Laboratories, Inc. (NASDAQ:MLAB) has declared a quarterly dividend of $0.16 per share, set to be paid on December 15, 2021. Shareholders must be on record by November 30, 2021. Mesa is a leading provider of quality control solutions across pharmaceutical, healthcare, and medical device sectors, with products segmented into four divisions aimed at ensuring safety and quality in these industries. The company cautions that future performance may be influenced by various risks including market demand fluctuations and economic uncertainties.
- Declaration of a quarterly dividend of $0.16 per share, signaling confidence in financial stability.
- The dividend payment on December 15, 2021, provides direct income to shareholders.
- Forward-looking statements indicate potential risks related to demand fluctuations and economic conditions.
Lakewood, Colo., Oct. 01, 2021 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today announced that its Board of Directors has declared a regular quarterly dividend of
About Mesa Laboratories, Inc.
Mesa is a global leader in the design and manufacturing of critical quality control solutions for the pharmaceutical, healthcare and medical device industries. Mesa offers products and services through four divisions (Sterilization and Disinfection Control, Biopharmaceutical Development, Instruments and Continuous Monitoring) to help our customers ensure product integrity, increase patient and worker safety, and improve the quality of life throughout the world.
Forward Looking Statements
This press release may contain information that constitutes forward-looking statements. Forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from our historical experience and present expectations or projections. Forward-looking statements include statements relating to revenues and growth, operating results, profit margin pressure, industry conditions, economic conditions, demand, competition, the effects of additional actions taken to become more efficient or lower costs, risks related to the integration of acquired businesses, changes in legal and regulatory matters, the ability to generate additional cash flow, and the duration and impact of the COVID-19 pandemic and the myriad of its effects on our business including related decreases in customer demand and spending, and any events or developments that we expect or anticipate will occur in the future. Generally, the words “expect,” “seek,” “anticipate,” “intend,” “plan,” “believe,” “could,” “estimate,” “may,” “target,” “project,” and similar expressions identify forward-looking statements. However, the absence of these words or similar expressions does not mean that a statement is not forward-looking. These statements are based upon current information and expectations. Actual results may differ materially from those estimated or anticipated as a result of these risks and unknowns or other risks and uncertainties. For additional information concerning these and other risks and uncertainties that could affect these statements, and the our business, see our Annual Report on Form 10-K for the year ended March 31, 2021, as well as other risks and uncertainties detailed from time to time in our reports on Forms 10-Q and 8-K subsequently filed with the Securities and Exchange Commission. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. We undertake no obligation to republish revised forward-looking statements to reflect events or circumstances after the date hereof, to provide any updates, or to reflect the occurrence of future events.
For more information about the Company, please visit its website at www.mesalabs.com
FAQ
What is the dividend amount declared by MLAB?
When will the MLAB dividend be paid?
What is the record date for MLAB's dividend?
How often does MLAB pay dividends?
What risks does MLAB mention regarding future performance?
